6,7-Dinitro-1,2,3,4-tetrahydroisoquinoline, 97%, 5g

Imidazole Hydrobromide (Low water content)>98.0%(HPLC)(T)1g

2-[(dimethylcarbamothioyl)sulfanyl]acetonitrile, 95%, 100mg

5-CHLOROHEXANOYL CHLORIDE, 95%, 50mg

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 1.00 µm, 1 Piece(s)

3-Fluoro-4-methylphenylboronic Acid (contains varying amounts of Anhydride)>97.0%(T)5g

1-(3-Bromo-4-methoxyphenyl)-2,2,2-trifluoroethan-1-amine, 97%, 250mg

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanol, 95.0%, 1g

2-Oxa-6-azaspiro[3.4]octane hemioxalate, 95.0%, 5g

4-((3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)morpholine, 98%, 1g

2-Methyl-4-pentenoic Acid>98.0%(GC)(T)10mL

1-(2,2,2-Trifluoroethyl)-1h-indol-6-amine, 98%, 500mg

N4-Acetylcytidine>95.0%(HPLC)(T)5g